Scheduling Actions- Chronological Order *Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULEAMPHETAMINE

05-26-71

07-07-71

36 FR 12734

7/7/1971

III --> II

METHAMPHETAMINE

05-26-71

07-07-71

36 FR 12734

7/7/1971

III --> II

BIPHETAMINE & BIPHETAMINE-T

05-26-71

07-23-71

36 FR 13686

7/23/1971

III --> II

FETAMIN

05-26-71

07-23-71

36 FR 13686

7/23/1971

III --> II

ESKATROL

05-26-71

08-18-71

36 FR 15744

8/18/1971

III --> II

NALOXONE HYDROCHLORIDE

08-19-71

09-29-71

36 FR 19116

9/29/1971

II --> NC

METHYLPHENIDATE

09-17-71

10-28-71

36 FR 20686

10/28/1971

III --> II

PHENMETRAZINE

09-17-71

10-28-71

36 FR 20686

10/28/1971

III --> II

01-29-72

37 FR 1468

1/29/1972I

PROPIRAMBENZPHETAMINE

05-09-73

06-15-73

38 FR 15719

6/15/1973

III

CHLORPHENTERMINE

05-09-73

06-15-73

38 FR 15719

6/15/1973

III

CLORTERMINE

05-09-73

06-15-73

38 FR 15719

6/15/1973

III

FENFLURAMINE

05-09-73

06-15-73

38 FR 15719

6/15/1973

IV

MAZINDOL

05-09-73

06-15-73

38 FR 15719

6/15/1973

III

PHENDIMETRAZINE

05-09-73

06-15-73

38 FR 15719

6/15/1973

III

DIETHYLPROPION

05-10-73

07-06-73

38 FR 18013

7/6/1973

IV

PHENTERMINE

05-09-73

07-06-73

38 FR 18013

7/6/1973

IV

07-03-73

38 FR 17717

8/6/1973

I

DROTEBANOL

2,5-DIMETHOXYAMPHETAMINE (DMA)

05-31-73

09-21-73

38 FR 26447

9/21/1973

I

4-BROMO-2,5-DIMETHOXYAMPHETAMINE

07-02-73

09-21-73

38 FR 26447

9/21/1973

I

4-METHOXYAMPHETAMINE (PMA)

07-02-73

09-21-73

38 FR 26447

9/21/1973I

METHAQUALONE

04-11-73

10-04-73

38 FR 27516

10/4/1973

II

AMOBARBITAL

05-31-73

11-13-73

38 FR 31310

11/13/1973

III --> II

PENTOBARBITAL

05-31-73

11-13-73

38 FR 31310

11/13/1973

III --> II

SECOBARBITAL

05-31-73

11-13-73

38 FR 31310

11/13/1973

III --> II

ETORPHINE HYDROCHLORIDE

11-23-73

03-29-74

39 FR 11535

4/19/1974

I --> IINALOXONE07-10-74

12-24-74

39 FR 44392

12/24/1974

II --> NC

PEMOLINE

11-07-74

01-28-75

40 FR 4150

1/28/1975

IV

MEBUTAMATE

12-13-74

01-30-75

40 FR 4418

1/30/1975

IV

CONCENTRATE OF POPPY STRAW

12-20-74

02-14-75

40 FR 6779

2/14/1975

II

NALTREXONE

12-09-74

03-06-75

40 FR 10455

3/6/1975

II --> NC

05-07-75

40 FR 19813

6/1/1975I

DIFENOXIN

Scheduling Actions - Chronological Order
29-Jul-24

Page 1 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULECHLORDIAZEPOXIDE

01-27-75

06-04-75

40 FR 23998

7/2/1975

IV

CLONAZEPAM

01-27-75

06-04-75

40 FR 23998

7/2/1975

IV

CLORAZEPATE

01-27-75

06-04-75

40 FR 23998

7/2/1975IV

DIAZEPAM

01-27-75

06-04-75

40 FR 23998

7/2/1975

IV

FLURAZEPAM

01-27-75

06-04-75

40 FR 23998

7/2/1975IVOXAZEPAM

01-27-75

06-04-75

40 FR 23998

7/2/1975IV

MECLOQUALONE

05-29-75

07-08-75

40 FR 28611

7/10/1975

I

TCP (PCP ANALOG)

05-29-75

07-08-75

40 FR 28611

8/11/1975I

LIBRAX

06-05-75

11-11-75

40 FR 52609

11/28/1975 Exempted
RX

MENRIUM06-05-75

11-11-75

40 FR 52609

11/28/1975 Exempted
RX

APOMORPHINE

04-08-76

06-28-76

41 FR 26568

6/28/1976

II --> NC

DEXTRORPHAN

04-19-76

10-01-76

41 FR 43401

10/1/1976

I --> NCNALBUPHINE

05-11-76

10-01-76

41 FR 43401

10/1/1976

II --> NC

PRAZEPAM

07-29-76

12-17-76

41 FR 55176

12/17/1976

IV

DEXTROPROPOXYPHENE

09-29-76

02-11-77

42 FR 8636

3/14/1977

IV

LOPERAMIDE

07-29-76

05-18-77

42 FR 25498

6/17/1977

V

LORAZEPAM

06-28-77

10-07-77

42 FR 54546

10/3/1977

IV

PHENCYCLIDINE (PCP)

12-19-77

01-25-78

43 FR 3359

2/24/1978

III --> II

PCC (PCP PRECURSOR)

03-20-78

05-17-78

43 FR 21324

6/16/1978

II

PCH (PCP PRECURSOR)

03-20-78

05-17-78

43 FR 21324

6/16/1978II

DIFENOXIN 1 MG WITH ATROPINE

06-26-78

08-28-78

43 FR 38382

9/27/1978

I --> IVDIFENOXIN 1/2 MG WITH ATROPINE

06-26-78

08-28-78

43 FR 38382

9/27/1978

I --> VPCE (PCP ANALOG)

08-11-78

09-25-78

43 FR 43295

10/25/1978

I

PHP (PCP ANALOG)

08-11-78

09-25-78

43 FR 43295

10/25/1978

I

PENTAZOCINE

09-13-78

01-10-79

44 FR 2169

2/9/1979

IV

TILIDINE

09-30-80

45 FR 64571

1/12/1980

I

PHENYLACETONE (P2P)

12-12-79

44 FR 71822

2/11/1980

II

06-24-80

45 FR 42264

7/24/1980

IV

DEXTROPROPOXYPHENE (BULK)

07-22-80

45 FR 48881

9/22/1980

IV --> IIPIPRADROL

09-30-80

45 FR 64570

12/1/1980

IV

SPA (LEFETAMINE)

09-30-80

45 FR 64570

12/1/1980

IV

SUFENTANIL

09-30-80

45 FR 64571

12/1/1980I

DEXTROPROPOXYPHENE

01-21-80

TEMAZEPAM

01-05-81

04-07-81

45 FR 20671

4/7/1981

IV

FENETHYLLINE

05-01-81

07-21-81

46 FR 37503

8/20/1981

I

ALPHA-METHYLFENTANYL

08-05-81

09-22-81

46 FR 46799

9/22/1981I

HALAZEPAM

04-29-81

10-29-81

46 FR 53407

10/29/1981

IV

ALPRAZOLAM

04-29-81

11-12-81

46 FR 55688

11/12/1981

IV

Scheduling Actions - Chronological Order
29-Jul-24

Page 2 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

MAZINDOL

04-17-81

10-27-81

46 FR 52333

11/27/1981

III --> IV

N-ETHYLAMPHETAMINE

09-10-81

12-08-81

46 FR 59969

1/7/1982

I

LOPERAMIDE

07-28-82

11-03-82

47 FR 49840

11/3/1982

V --> NC

PARAHEXYL

08-05-82

11-22-82

47 FR 52432

12/22/1982

I

TRIAZOLAM

04-29-81

12-28-82

47 FR 57694

12/28/1982

IV

SUFENTANIL

03-20-84

05-25-84

49 FR 22074

5/25/1984

I --> II

06-25-84

49 FR 25849

8/24/1984I

ALFENTANILMETHAQUALONE

08-27-84

49 FR 33870

8/27/1984

II --> I

BROMAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

CAMAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

CLOBAZAM

08-01-84

10-05-84

49 FR 39307

11/5/1984IV

CLOTIAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984IV

CLOXAZOLAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

DELORAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

ESTAZOLAM

08-01-84

10-05-84

49 FR 39307

11/5/1984IV

ETHYL LOFLAZEPATE

08-01-84

10-05-84

49 FR 39307

11/5/1984IV

FLUDIAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984IV

FLUNITRAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984IV

HALOXAZOLAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

KETAZOLAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

LOPRAZOLAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

LORMETAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

MEDAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

NIMETAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984IV

NITRAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

NORDIAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984IV

OXAZOLAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

PINAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984IVTETRAZEPAM

08-01-84

10-05-84

49 FR 39307

11/5/1984

IV

BUPRENORPHINE

09-20-82

02-28-85

50 FR 8104

4/1/1985

II --> V

3-METHYLFENTANYL *03-25-85

50 FR 11690

4/25/1985I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) *05-31-85

50 FR 23118

7/1/1985

I

MPPP *

07-10-85

50 FR 28098

8/12/1985

I

PEPAP *

07-10-85

50 FR 28098

8/12/1985I

NALMEFENE

11-04-85

50 FR 45815

11/4/1985

II --> NC

3-METHYLTHIOFENTANYL *05-31-85

10-29-85

50 FR 43698

11/29/1985

I

ACETYL-ALPHA-METHYLFENTANYL *10-29-85

50 FR 43698

11/29/1985

I

ALPHA-METHYLTHIOFENTANYL *10-29-85

50 FR 43698

11/29/1985

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 3 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULEBENZYLFENTANYL*

10-29-85

50 FR 43698

11/29/1985

I Expired
11/29/86

BETA-HYDROXY-3-METHYLFENTANYL *10-29-85

50 FR 43698

11/29/1985

I

BETA-HYDROXYFENTANYL *10-29-85

50 FR 43698

11/29/1985

I

THENYLFENTANYL *10-29-85

50 FR 43698

11/29/1985

I Expired
11/29/86

THIOFENTANYL *10-29-85

50 FR 43698

11/29/1985

I

PARA-FLUOROFENTANYL *02-07-86

51 FR 4722

3/10/1986

I

MIDAZOLAM

02-07-86

03-25-86

51 FR 10190

3/25/1986

IV

QUAZEPAM

02-07-86

03-25-86

51 FR 10190

3/25/1986

IV

04-24-86

51 FR 15474

4/25/1986

I

05-13-86

51 FR 17476

5/13/1986

I --> IIMDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) **06-17-86

51 FR 21911

7/1/1986

I

MPPP **

08-11-86

51 FR 28695

8/12/1986

I

PEPAP **

08-11-86

51 FR 28695

8/12/1986

I

3-METHYLFENTANYL **DRONABINOL PRODUCT (MARINOL)

10-18-85

3-METHYLFENTANYL

04-24-86

09-22-86

51 FR 33592

9/22/1986

I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)

07-27-84

10-14-86

51 FR 36552

11/13/1986

I

3-METHYLTHIOFENTANYL **11-26-86

51 FR 42834

11/29/1986

I

ACETYL-ALPHA-METHYLFENTANYL **11-26-86

51 FR 42834

11/29/1986

I

ALPHA-METHYLTHIOFENTANYL **11-26-86

51 FR 42834

11/29/1986

I

BETA-HYDROXY-3-METHYLFENTANYL **11-26-86

51 FR 42834

11/29/1986

I Expired
5/29/87

BETA-HYDROXYFENTANYL **11-26-86

51 FR 42834

11/29/1986

I

THIOFENTANYL **11-26-86

51 FR 42834

11/29/1986

I

ALFENTANIL

04-17-86

01-23-87

52 FR 2516

1/23/1987

I --> II

MPPP

08-11-86

01-23-87

52 FR 2515

1/23/1987

I

PEPAP

08-11-86

01-23-87

52 FR 2515

1/23/1987I

TILETAMINE/ZOLAZEPAM (TELAZOL)

08-11-86

01-21-87

52 FR 2221

2/20/1987

III

PARA-FLUOROFENTANYL **03-10-87

52 FR 7270

3/10/1987

I

NABILONE

06-18-86

04-07-87

52 FR 11042

4/7/1987

II

3-METHYLTHIOFENTANYL

11-28-86

05-29-87

52 FR 20070

5/29/1987I

ACETYL-ALPHA-METHYLFENTANYL

11-28-86

05-29-87

52 FR 20070

5/29/1987

I

ALPHA-METHYLTHIOFENTANYL

11-28-86

05-29-87

52 FR 20070

5/29/1987

I

BETA-HYDROXYFENTANYL

11-28-86

05-29-87

52 FR 20070

5/29/1987

I

PARA-FLUOROFENTANYL

03-10-87

05-29-87

52 FR 20070

5/29/1987

I

THIOFENTANYL

11-28-86

05-29-87

52 FR 20070

5/29/1987

I

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE;
MDEA) *

10-15-87

52 FR 38225

10/15/1987

I

4-METHYLAMINOREX *10-15-87

52 FR 38225

10/15/1987

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 4 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATE

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE *FEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE
10-15-87

52 FR 38225

10/15/1987

I

01-08-88

53 FR 500

1/8/1988

I

MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)

01-27-88

53 FR 2225

1/27/1988

I --> NCMDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE)

02-22-88

53 FR 5156

3/23/1988

I

BETA-HYDROXY-3-METHYLFENTANYL

11-28-86

PROPYLHEXEDRINE

10-30-87

04-04-88

53 FR 10869

5/4/1988

V

PYROVALERONE

10-30-87

04-04-88

53 FR 10869

5/4/1988

V

CATHINE

10-30-87

05-17-88

53 FR 17459

6/16/1988

IV

FENCAMFAMIN

10-30-87

05-17-88

53 FR 17459

6/16/1988

IV

FENPROPOREX

10-30-87

05-17-88

53 FR 17459

6/16/1988

IV

MEFENOREX

10-30-87

05-17-88

53 FR 17459

6/16/1988

IV

N,N-DIMETHYLAMPHETAMINE *08-03-88

53 FR 29232

8/3/1988

I

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE;
MDEA) **

10-13-88

53 FR 40061

10/13/1988

I

4-METHYLAMINOREX **10-13-88

53 FR 40061

10/13/1988

I

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE **10-13-88

53 FR 40061

10/13/1988

I

CARFENTANIL

01-12-88

10-28-88

53 FR 43684

10/28/1988

II

3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE;
MDEA)

10-14-88

04-13-89

54 FR 14797

4/13/1989

I

4-METHYLAMINOREX

10-14-88

04-13-89

54 FR 14799

4/13/1989

I

N-HYDROXY-3,4-METHYLENEDIOXYAMPHETAMINE

10-14-88

04-13-89

54 FR 14797

4/13/1989I

1-[1-(2-THIENYL)CYCLOHEXYL]PYRROLIDINE

03-20-89

07-06-89

54 FR 28414

7/6/1989

I

08-02-89

54 FR 31815

8/2/1989

I

N,N-DIMETHYLAMPHETAMINE **N,N-DIMETHYLAMPHETAMINE

08-02-89

02-02-90

55 FR 3586

2/2/1990

I

ANABOLIC STEROIDS

PL 101-647

02-13-91

56 FR 5753

2/27/1991

III

GLUTETHIMIDE

07-26-90

03-21-91

56 FR 11930

3/21/1991

III --> II12-03-91

56 FR 61372

12/3/1991

V --> NC

05-01-92

57 FR 18824

5/1/1992

I

07-14-92

57 FR 31126

7/14/1992

II --> NC
Superseded
10/97

09-21-92

57 FR 43399

9/21/1992

I

PROPYLHEXEDRINEMETHCATHINONE *BUTORPHANOL, THEBAINE DERIVED

04-03-92

AMINOREX *ZOLPIDEM

11-24-92

02-05-93

58 FR 7186

2/5/1993

IV

2,5-DIMETHOXY-4-ETHYLAMPHETAMINE (DOET)

10-30-87

01-14-93

58 FR 4316

2/16/1993

I

CATHINONE

10-30-87

01-14-93

58 FR 4316

2/16/1993

I

ALPHA-ETHYLTRYPTAMINE *03-12-93

58 FR 13533

3/12/1993

I

METHCATHINONE **04-29-93

58 FR 25934

5/1/1993

I

08-18-93

58 FR 43795

8/18/1993

I --> II

08-24-93

58 FR 44611

9/21/1993I

10-15-93

58 FR 53404

10/15/1993

I

LEVO-ALPHACETYLMETHADOL (LAAM)

04-28-93

AMINOREX **METHCATHINONE

04-28-93

Scheduling Actions - Chronological Order
29-Jul-24

Page 5 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE *01-06-94

59 FR 00671

1/6/1994

I

ALPHA-ETHYLTRYPTAMINE **03-07-94

59 FR 10720

3/12/1994

I

AMINOREX

08-20-93

03-18-94

59 FR 12828

3/18/1994

I

ALPHA-ETHYLTRYPTAMINE

03-07-94

09-12-94

59 FR 46757

9/12/1994

I

12-21-94

59 FR 65710

1/6/1995

I

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE **4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE

12-20-94

06-02-95

60 FR 28718

6/2/1995

I

REMIFENTANIL

09-16-96

11-05-96

61 FR 56893

11/5/1996

II

FENFLURAMINE

05-06-97

05-06-97

62 FR 24620

BUTORPHANOL

07-10-97

10-01-97

62 FR 51370

10/31/1997

IV

SIBUTRAMINE

12-08-97

02-11-98

63 FR 6862

2/11/1998

IV

MODAFINIL

04-14-98

01-27-99

64 FR 4050

1/27/1999

IV

DRONABINOL PRODUCT (MARINOL)

11-05-98

07-02-99

64 FR 35928

7/2/1999

II -> IIIKETAMINE

04-09-99

07-13-99

64 FR 37673

8/12/1999

III

ZALEPLON

05-05-99

09-15-99

64 FR 49982

9/15/1999

IV

GAMMA HYDROXYBUTYRIC ACID (GHB)

PL 106-172

03-13-00

65 FR 13235

3/13/2000

IGAMMA HYDROXYBUTYRIC ACID (GHB) FDA approved drug
products

PL 106-172

03-13-00

65 FR 13235

3/13/2000

III

11-17-00

65 FR 69442

11/17/2000 clarificationof CII
control

08-16-01

66 FR 42943

8/16/2001 clarificationof CIV
control

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) *09-20-02

67 FR 59161

9/20/2002

I

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2CT-7) *09-20-02

67 FR 59163

9/20/2002

I

N-BENZYLPIPERAZINE (BZP) *09-20-02

67 FR 59161

9/20/2002

I

10-07-02

67 FR 62354

10/7/2002

V --> III

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT) *04-04-03

68 FR 16427

4/4/2003

I

ALPHA-METHYLTRYPTAMINE (AMT) *04-04-03

68 FR 16427

4/4/2003

I

05-15-03

68 FR 26247

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP) **09-10-03

68 FR 53289

9/20/2003

I

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2CT-7) **09-10-03

68 FR 53289

9/20/2003

I

N-BENZYLPIPERAZINE (BZP) **09-10-03

68 FR 53289

9/20/2003

I

DIHYDROETORPHINE (thebaine derivative)

DICHLORALPHENAZONE (chloral hydrate compound)

BUPRENORPHINE

FENFLURAMINE

12-11-00

03-21-02

05-06-97

IV --> NCIV
Withdrew
97
proposedrule

2,5-DIMETHOXY-4-(n)-PROPYLTHIOPHENETHYLAMINE (2CT-7)

09-08-03

03-18-04

69 FR 12794

3/18/2004

I

N-BENZYLPIPERAZINE (BZP)

09-08-03

03-18-04

69 FR 12794

3/18/2004

I

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE (TFMPP)

09-08-03

03-18-04

69 FR 12794

3/19/2004

I --> NC

Scheduling Actions - Chronological Order
29-Jul-24

Page 6 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT)**

04-01-04

69 FR 17034

4/1/2004

I

ALPHA-METHYLTRYPTAMINE (AMT) **04-01-04

69 FR 17034

4/1/2004

I

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE (5-MeO-DIPT)

09-29-04

69 FR 58050

9/29/2004

I

ALPHA-METHYLTRYPTAMINE (AMT)

09-29-04

69 FR 58050

9/29/2004

I

ZOPICLONE

02-14-05

04-04-05

70 FR 16935

4/4/2005

IV

PREGABALIN

05-12-05

07-28-05

70 FR 43633

7/28/2005

V

ANABOLIC STEROIDS

PL 108-358

12-16-05

70 FR 74653

1/17/2006

III

EMBUTRAMIDE

07-29-05

08-29-06

71 FR 51115

9/28/2006

III

LISDEXAMFETAMINE

02-22-07

05-03-07

72 FR 24532

6/4/2007

II

09-24-07

72 FR 54208

9/24/2007

II

1/31/2008

IV

ORIPAVINE
INDIPLON

01-31-08

01-31-08

LACOSAMIDE

03-10-09

05-21-09

74 FR 23789

6/22/2009V

TAPENTADOL

02-17-09

05-21-09

74 FR 23790

6/22/2009IIFOSPROPOFOL

07-23-09

10-06-09

74 FR 51234

11/5/2009

IV

19-NOR-4,9(10)-ANDROSTADIENEDIONE (estra-4,9(10)-diene- 04-25-08
3,17-dione)

12-04-09

74 FR 63603

1/4/2010

III

BOLDIONE (Androsta-1,4-diene-3,17-dione)

04-25-08

12-04-09

74 FR 63603

1/4/2010

III

DESOXYMETHYLTESTOSTERONE (17a-methyl-5a-androst-2en-17-ol, madol)

04-25-08

12-04-09

74 FR 63603

1/4/2010

III

4-ANILINO-N-PHENETHYL-4-PIPERIDINE (ANPP)

04-09-08

06-29-10

75 FR 37296

8/30/2010

II

5-METHOXY-N,N-DIMETHYLTRYPTAMINE

08-21-09

12-20-10

75 FR 79296

1/19/2011I

CP-47,497 *

03-01-11

76 FR 11075

3/1/2011

I

CP-47,497 C8 HOMOLOGUE *03-01-11

76 FR 11075

3/1/2011

I

JWH-018 *03-01-11

76 FR 11075

3/1/2011

I

JWH-073 *03-01-11

76 FR 11075

3/1/2011

I

JWH-200 *03-01-11

76 FR 11075

3/1/2011

I

3,4-METHYLENEDIOXY-N-METHYLCATHINONE(METHYLONE) *10-21-11

76 FR 65371

10/21/2011

I

3,4-METHYLENEDIOXYPYROVALERONE (MDPV) *10-21-11

76 FR 65371

10/21/2011

I

4-METHYL-N-METHYLCATHINONE (MEPHEDRONE) *10-21-11

76 FR 65371

10/21/2011

I

EZOGABINE

10-21-11

12-15-11

76 FR 77895

12/15/2011

V

CARISOPRODOL

11-17-09

12-12-11

76 FR 77330

1/11/2012

IV

CP-47,497 **02-29-12

77 FR 12201

2/29/2012I

CP-47,497 C8 HOMOLOGUE **02-29-12

77 FR 12201

2/29/2012

I

JWH-018 **02-29-12

77 FR 12201

2/29/2012

I

JWH-073 **02-29-12

77 FR 12201

2/29/2012

I

JWH-200 **02-29-12

77 FR 12201

2/29/2012I

07-30-12

77 FR 44456

8/29/2012III

METHASTERONE (2 ALPHA-17 ALPHA-DIMETHYL-5 ALPHAANDROSTAN-17BETA-OL-3-ONE)

11-23-11

Scheduling Actions - Chronological Order
29-Jul-24

Page 7 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULEPROSTANOZOL (17 BETA-HYDROXY-5 ALPHAANDROSTANO[3,2-C]PRYAZOLE)

11-23-11

07-30-12

77 FR 44456

8/29/2012

III

3,4-METHYLENEDIOXY-N-METHYLCATHINONE(METHYLONE)

10-21-11

04-12-13

78 FR 21818

4/12/2013

I(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) *05-16-13

78 FR 28735

5/16/2013

I[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUOROUR-144, XLR11) *05-16-13

78 FR 28735

5/16/2013

I

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3CARBOXAMIDE (APINACA, AKB48) *05-16-13

78 FR 28735

5/16/2013I

05-08-13

78 FR 26701

6/7/2013

IV

2-(4-BROMO-2,5-DIMETHOXYPHENYL)-N-(2METHOXYBENZYL)ETHANAMINE (25B-NBOMe) *11-15-13

78 FR 68716

11/15/2013

I

2-(4-CHLORO-2,5-DIMETHOXYPHENYL)-N-(2METHOXYBENZYL)ETHANAMINE (25C-NBOMe) *11-15-13

78 FR 68716

11/15/2013

I

2-(4-IODO-2,5-DIMETHOXYPHENYL)-N-(2-METHOXYBENZYL)ETHANAMINE (25I-NBOMe) *11-15-13

78 FR 68716

11/15/2013

I12-02-13

78 FR 72013

1/2/2014

III

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) *02-10-14

79 FR 7577

2/10/2014

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ABFUBINACA) *02-10-14

79 FR 7577

2/10/2014

I

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) *02-10-14

79 FR 7577

2/10/2014

I

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE(PB–22; QUPIC) *02-10-14

79 FR 7577

2/10/2014I

02-27-14

79 FR 10985

3/31/2014

IV

3-FLUORO-N-METHYLCATHINONE (3-FMC) *03-07-14

79 FR 12938

3/7/2014

I

4-FLUORO-N-METHYLCATHINONE (4-FMC) *03-07-14

79 FR 12938

3/7/2014

I

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4MePPP) *03-07-14

79 FR 12938

3/7/2014

I

4-METHYL-N-ETHYLCATHINONE (4-MEC) *03-07-14

79 FR 12938

3/7/2014

I

ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) *03-07-14

79 FR 12938

3/7/2014

I

ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) *03-07-14

79 FR 12938

3/7/2014

I

BUTYLONE *03-07-14

79 FR 12938

3/7/2014

I

NAPHYRONE *03-07-14

79 FR 12938

3/7/2014

I

PENTEDRONE *03-07-14

79 FR 12938

3/7/2014

I

LORCASERINPERAMPANEL [2-(2-OXO-1-PHENYL-5-PYRIDIN-2-YL-l ,2DIHYDROPYRIDIN-3-YL)BENZONITRILE]

ALFAXALONE (5α-PREGNAN-3α-OL-11,20-DIONE)

12-19-12

10-22-13

03-25-13

PENTYLONE *03-07-14

79 FR 12938

3/7/2014

I

TRAMADOL (2-[(DIMETHYLAMINO)METHYL]-1-(3METHOXYPHENYL)CYCLOHEXANOL)

11-04-13

07-02-14

79 FR 37623

8/18/2014

IV

SUVOREXANT

02-13-14

08-28-14

79 FR 52143

9/29/2014IV

HYDROCODONE COMBINATION PRODUCTS

02-27-14

08-22-14

79 FR 49661

10/6/2014

III --> II

Scheduling Actions - Chronological Order
29-Jul-24

Page 8 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATENALOXEGEL

10-29-14

FEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE
01-23-15

80 FR 3468

1/23/2015

II --> NC[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1YL)METHANONE (THJ-2201) *01-30-15

80 FR 5042

1/30/2015

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1(CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (ABCHMINACA) *01-30-15

80 FR 5042

1/30/2015

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1HINDAZOLE-3-CARBOXAMIDE (AB-PINACA) *01-30-15

80 FR 5042

1/30/2015

I(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144) **05-15-15

80 FR 27854

5/15/2015

I[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUOROUR-144, XLR11) **05-15-15

80 FR 27854

5/5/2015

I

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3CARBOXAMIDE (APINACA, AKB48) **05-15-15

80 FR 27854

5/15/2015

I

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLACETAMIDE) *07-17-15

80 FR 42381

7/17/2015

I[123I]IOFLUPANE

06-03-15

09-11-15

80 FR 54715

9/11/2015

II --> NC

ELUXADOLINE

08-11-15

11-12-15

80 FR 69861

12/17/2015

IVN-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE(MAB-CHMINACA) *02-05-16

81 FR 6171

2/5/2016

I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA) **02-05-16

81 FR 6175

2/5/2016

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ABFUBINACA) **02-05-16

81 FR 6175

2/5/2016

I

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXYLATE (5-FLUORO-PB–22; 5F–PB–22) **02-05-16

81 FR 6175

2/5/2016

I

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE(PB–22; QUPIC) **02-05-16

81 FR 6175

2/5/2016

I

3-FLUORO-N-METHYLCATHINONE (3-FMC) **03-04-16

81 FR 11429

3/4/2016

I

4-FLUORO-N-METHYLCATHINONE (4-FMC) **03-04-16

81 FR 11429

3/4/2016

I

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4MePPP) **03-04-16

81 FR 11429

3/4/2016

I

4-METHYL-N-ETHYLCATHINONE (4-MEC) **03-04-16

81 FR 11429

3/4/2016

I

ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP) **03-04-16

81 FR 11429

3/4/2016

I

ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP) **03-04-16

81 FR 11429

3/4/2016

I

BUTYLONE **03-04-16

81 FR 11429

3/4/2016

I

NAPHYRONE **03-04-16

81 FR 11429

3/4/2016

I

PENTEDRONE **03-04-16

81 FR 11429

3/4/2016

I

PENTYLONE **03-04-16

81 FR 11429

3/4/2016

I(1-PENTYL-1H-INDOL-3-YL)(2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE (UR-144)

05-11-16

81 FR 29142

5/11/2016I[1-(5-FLUORO-PENTYL)1H-INDOL-3-YL](2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE(5-FLUOROUR-144, XLR11)

05-11-16

81 FR 29142

5/11/2016

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 9 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3CARBOXAMIDE (APINACA, AKB48)

05-11-16

81 FR 29142

5/11/2016

I

BETA-HYDROXYTHIOFENTANYL *05-12-16

81 FR 29492

5/12/2016

I

BRIVARACETAM (BRV; UCB-34714; BRIVIACT)

05-12-16

81 FR 29487

5/12/2016

V

BUTYRYL FENTANYL*

05-12-16

81 FR 29492

5/12/2016

I

3,4-DICHLORO-N-[(1DIMETHYLAMINO)CYCLOHEXYLMETHYL]BENZAMIDE)(AH-7921)

04-14-16

81 FR 22023

5/15/2016

I

THIAFENTANIL

08-26-16

81 FR 58834

8/26/2016

II

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL1H-INDAZOLE-3-CARBOXAMIDE (ADB-PINACA)

09-06-16

81 FR 61130

9/6/2016

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ABFUBINACA)

09-06-16

81 FR 61130

9/6/2016

I

QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXYLATE (5-FLUORO-PB-22; 5F-PB-22)

09-06-16

81 FR 61130

9/6/2016

I

QUINOLIN-8-YL 1-PENTYL-1H-INDOLE-3-CARBOXYLATE (PB22; QUPIC)

09-06-16

81 FR 61130

9/6/2016

I

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-NMETHYLBENZAMIDE (U-47700) *11-14-16

81 FR 79389

11/14/2016

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2CARBOXAMIDE (FURANYL FENTANYL) *11-29-16

81 FR 85873

11/29/2016

I

3-FLUORO-N-METHYLCATHINONE (3-FMC)

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

4-FLUORO-N-METHYLCATHINONE (4-FMC)

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

4-METHYL-ALPHAPYRROLIDINOPROPIOPHENONE (4MePPP)

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

4-METHYL-N-ETHYLCATHINONE (4-MEC)

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

ALPHA-PYRROLIDINOBUTIOPHENONE (α-PBP)

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

ALPHA-PYRROLIDINOPENTIOPHENONE (α-PVP)

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

BUTYLONE

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

NAPHYRONE

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

PENTEDRONE

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

PENTYLONE

03-04-16

03-01-17

82 FR 12171

3/1/2017

I

DRONABINOL IN ORAL SOLUTION IN DRUG PRODUCTAPPROVED FOR MARKETING BY U.S. FOOD AND DRUG
ADMIN.

03-23-17

82 FR 14815

3/23/2017

II

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE(MDMB–FUBINACA) *04-10-17

82 FR 17119

4/10/2017

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB, 5FMDMB-PINACA) *04-10-17

82 FR 17119

4/10/2017

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) *04-10-17

82 FR 17119

4/10/2017

I

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMBCHMICA) *04-10-17

82 FR 17119

4/10/2017

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 10 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE(ADB–FUBINACA) *04-10-17

82 FR 17119

4/10/2017

I

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE3-CARBOXAMIDE (5F–APINACA, 5F–AKB48) *04-10-17

82 FR 17119

4/10/2017

I

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL) *05-03-17

82 FR 20544

5/3/2017

I

ACETYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLACETAMIDE)

06-07-17

82 FR 26349

6/7/2017I

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLACRYLAMIDE) *07-14-17

82 FR 32453

7/14/2017I[1-(5-FLUOROPENTYL)-1H-INDAZOL-3-YL](NAPHTHALEN-1YL)METHANONE (THJ-2201)

10-16-17

82 FR 47971

10/16/2017

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1(CYCLOHEXYLMETHYL)1H-INDAZOLE-3-CARBOXAMIDE (ABCHMINACA)

10-16-17

82 FR 47971

10/16/2017

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1HINDAZOLE-3-CARBOXAMIDE (AB-PINACA)

10-16-17

82 FR 47971

10/16/2017

I

METHOXYACETYL FENTANYL (2-METHOXY-N-(1PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE) *10-26-17

82 FR 49504

10/26/2017

I

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)) *10-26-17

82 FR 49504

10/26/2017

I

TETRAHYDROFURANYL FENTANYL (N-(1PHENETHYLPIPERIDIN-4-YL)-NPHENYLTETRAHYDROFURAN-2-CARBOXAMIDE) *10-26-17

82 FR 49504

10/26/2017

I

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3METHYLBUTANOATE *11-03-17

82 FR 51154

11/3/2017I

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE) *01-04-18

83 FR 469

1/4/2018

I

MT-45 (1-CYCLOHEXYL-4-(1,2DIPHENYLETHYL)PIPERAZINE))

12-13-17

82 FR 58557

1/12/2018

I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE(MAB-CHMINACA) **01-30-18

83 FR 4411

1/30/2018

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYLFENTANYL) *02-01-18

83 FR 4580

2/1/2018

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) *02-01-18

83 FR 4580

2/1/2018

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE(VALERYL FENTANYL) *02-01-18

83 FR 4580

2/1/2018

I

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL) *02-01-18

83 FR 4580

2/1/2018

I

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYLFENTANYL)*

02-01-18

83 FR 4580

2/1/2018

I

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL) *02-01-18

83 FR 4580

2/1/2018

I

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) *02-01-18

83 FR 4580

2/1/2018

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 11 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULEFENTANYL-RELATED SUBSTANCES, AS DEFINED IN 21
CFR 1308.11(h)*02-06-18

83 FR 5188

2/6/2018

I

3,4-DICHLORO-N-[2-(DIMETHYLAMINO)CYCLOHEXYL]-NMETHYLBENZAMIDE (U-47700)

04-20-18

83 FR 17486

4/20/2018

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE(BUTYRYL FENTANYL)

04-20-18

83 FR 17486

4/20/2018

I

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1HINDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) *07-10-18

83 FR 31877

7/10/2018

I

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1HPYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYLP7AICA) *07-10-18

83 FR 31877

7/10/2018

I

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA,
AMB-CHMICA) *07-10-18

83 FR 31877

7/10/2018

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-ABPINACA) *07-10-18

83 FR 31877

7/10/2018I

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXYLATE (NM2201; CBL2201) *07-10-18

83 FR 31877

7/10/2018

I

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1ONE (N-ETHYLPENTYLONE, EPHYLONE) *08-31-18

83 FR 44474

8/31/2018

I

APPROVED CANNABIDIOL DRUGS , AS DEFINED IN 21 CFR
1308.15(f)09-28-18

83 FR 48953

9/28/2018V

ACRYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLACRYLAMIDE)

11-29-18

83 FR 61320

11/29/2018

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLFURAN-2CARBOXAMIDE (FURANYL FENTANYL)

11-29-18

83 FR 61320

11/29/2018

I

N-(2-FLUOROPHENYL)-2-METHOXY-N-(1PHENETHYLPIPERIDIN-4-YL)ACETAMIDE (OCFENTANIL)

11-29-18

83 FR 61320

11/29/2018

I

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)ISOBUTYRAMIDE (4-FLUOROISOBUTYRYL FENTANYL)

11-29-18

83 FR 61320

11/29/2018

I

TETRAHYDROFURANYL FENTANYL (N-(1PHENETHYLPIPERIDIN-4-YL)-NPHENYLTETRAHYDROFURAN-2-CARBOXAMIDE)

11-29-18

83 FR 61320

11/29/2018

I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE(MAB-CHMINACA)

01-29-19

84 FR 444

1/29/2019

I

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMBFUBINACA) **04-08-19

84 FR 13796

4/8/2019

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB, 5FMDMB-PINACA) **04-08-19

84 FR 13796

4/8/2019

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB) **04-08-19

84 FR 13796

4/8/2019

I

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMBCHMICA) **04-08-19

84 FR 13796

4/8/2019

I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE(ADB–FUBINACA) **04-08-19

84 FR 13796

4/8/2019

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 12 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE3-CARBOXAMIDE (5F-APINACA, 5F-AKB48) **04-08-19

84 FR 13796

4/8/2019

I(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) *04-16-19

84 FR 15505

4/16/2019I

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1HINDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) *04-16-19

84 FR 15505

4/16/2019I

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMBPINACA) *04-16-19

84 FR 15505

4/16/2019

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMBPICA) *04-16-19

84 FR 15505

4/16/2019

I

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) *04-16-19

84 FR 15505

4/16/2019

I

BETA-HYDROXYTHIOFENTANYL

05-08-19

84 FR 20023

5/8/2019

I

BREXANOLONE (3Α-HYDROXY-5Α-PREGNAN-20-ONE),ALLOPREGNANOLONE

06-17-19

84 FR 27938

6/17/2019IV

SOLRIAMFETOL (2-AMINO-3-PHENYLPROPYL CARBAMATE; BENZENEPROPANOL,BETA-AMINO-, CARBAMATE(ESTER))

06-17-19

84 FR 27943

6/17/2019IV

4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP) *07-18-19

84 FR 34291

7/18/2019

I

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4CHLORO-A-PVP) *07-18-19

84 FR 34291

7/18/2019I

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4MEAP) *07-18-19

84 FR 34291

7/18/2019I

ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) *07-18-19

84 FR 34291

7/18/2019I

ALPHA-PYRROLIDINOHEXANOPHENONE (A-PHP) *07-18-19

84 FR 34291

7/18/2019

I

N-ETHYLHEXEDRONE *07-18-19

84 FR 34291

7/18/2019I

CYCLOPROPYL FENTANYL (N-(1-PHENETHYLPIPERIDIN-4YL)-N-PHENYLCYCLOPROPANECARBOXAMIDE)

10-25-19

84 FR 57323

10/25/2019

I

METHOXYACETYL FENTANYL (2-METHOXY-N-(1PHENETHYLPIPERIDIN-4-YL)-N-PHENYLACETAMIDE)

10-25-19

84 FR 57323

10/25/2019

I

N-(4-FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)BUTYRAMIDE (PARA-FLUOROBUTYRYL FENTANYL)

10-25-19

84 FR 57323

10/25/2019

I

ORTHO-FLUOROFENTANYL OR 2-FLUOROFENTANYL (N-(2FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL))

10-25-19

84 FR 57323

10/25/2019

I

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3METHYLBUTANOATE **10-30-19

84 FR 58045

11/3/2019

I

6β-NALTREXOL ((5a,6β)-17-(CYCLOPROPYLMETHYL)-4,5EPOXYMORPHINAN-3,6,14-TRIOL)

01-24-20

85 FR 4215

1/24/2020

II --> NC

METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMBFUBINACA)

01-24-20

85 FR 4211

1/24/2020

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-ADB, 5FMDMB-PINACA)

01-24-20

85 FR 4211

1/24/2020

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3-METHYLBUTANOATE (5F-AMB)

01-24-20

85 FR 4211

1/24/2020

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 13 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULEMETHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (MDMBCHMICA)

01-24-20

85 FR 4211

1/24/2020

I

N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE (ADBFUBINACA)

01-24-20

85 FR 4211

1/24/2020

I

N-(ADAMANTAN-1-YL)-1-(5-FLUOROPENTYL)-1H-INDAZOLE3-CARBOXAMIDE (5F-APINACA, 5F-AKB48)

01-24-20

85 FR 4211

1/24/2020I

LASMIDITAN [2,4,6-TRIFLUORO-N-(6-(1-METHYLPIPERIDINE4-CARBONYL)PYRIDINE-2-YL-BENZAMIDE]

01-31-20

85 FR 5557

1/31/2020

V

N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYLFENTANYL) **01-30-20

85 FR 5321

2/1/2020

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL) **01-30-20

85 FR 5321

2/1/2020

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE(VALERYL FENTANYL) **01-30-20

85 FR 5321

2/1/2020

I

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYLFENTANYL)**

01-30-20

85 FR 5321

2/1/2020

I

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL) **01-30-20

85 FR 5321

2/1/2020I

CENOBAMATE [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2YL)ETHYL]CARBAMATE

03-10-20

85 FR 13741

3/10/2020

V

FUB-AMB, MMB-FUBINACA (METHYL 2-(1-(4FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDO)-3METHYLBUTANOATE

03-30-20

85 FR 17494

3/30/2020

I

LEMBOREXANT

04-07-20

85 FR 19387

4/7/2020

IV

04-17-20

85 FR 21320

5/18/2020

IIETHYLONE06-08-20

85 FR 34607

6/8/2020

I

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1HINDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA) **07-13-20

85 FR 42296

7/10/2020

I

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1HPYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYLP7AICA) **07-13-20

85 FR 42296

7/10/2020

I

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA,
AMB-CHMICA) **07-13-20

85 FR 42296

7/10/2020

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-ABPINACA) **07-13-20

85 FR 42296

7/10/2020I

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXYLATE (NM2201; CBL2201) **07-13-20

85 FR 42296

7/10/2020

I

ISOTONITAZENE (N,N-DIETHYL-2-(2-(4ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1YL)ETHAN-1-AMINE) *08-20-20

85 FR 51342

8/20/2020

I

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1ONE (N-ETHYLPENTYLONE, EPHYLONE) **08-27-20

85 FR 52915

8/31/2020

I

CROTONYL FENTANYL ((E)-N-(1-PHENETHYLPIPERIDIN-4YL)-N-PHENYLBUT-2-ENAMIDE)

10-02-20

85 FR 62215

10/2/2020INORFENTANYL (N-PHENYL-N-(PIPERIDIN-4YL)PROPIONAMIDE)

09-17-19

Scheduling Actions - Chronological Order
29-Jul-24

Page 14 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

REMIMAZOLAM (4H-IMIDAZOL[1,2-A][1,4]BENZODIAZEPINE4-PROPIONIC ACID)

10-06-20

85 FR 63014

10/6/2020

IV

OLICERIDINE

10-30-20

85 FR 68749

10/30/2020

IIN-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLCYCLOPENTANECARBOXAMIDE (CYCLOPENTYLFENTANYL)

11-25-20

85 FR 75231

11/25/2020

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-NPHENYLISOBUTYRAMIDE (ISOBUTYRYL FENTANYL)

11-25-20

85 FR 75231

11/25/2020

I

N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPENTANAMIDE(VALERYL FENTANYL)

11-25-20

85 FR 75231

11/25/2020

I

N-(4-CHLOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)ISOBUTYRAMIDE (PARA-CHLOROISOBUTYRYLFENTANYL)

11-25-20

85 FR 75231

11/25/2020

I

N-(4-METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)BUTYRAMIDE (PARA-METHOXYBUTYRYL FENTANYL)

11-25-20

85 FR 75231

11/25/2020

I

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE) *03-01-21

86 FR 11862

3/1/2021

I(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144) **03-31-21

86 FR 16669

4/16/2021I

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1HINDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25) **03-31-21

86 FR 16669

4/16/2021

I

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMBPINACA) **03-31-21

86 FR 16669

4/16/2021

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMBPICA) **03-31-21

86 FR 16669

4/16/2021

I

N-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA) **03-31-21

86 FR 16669

4/16/2021

I

SAMIDORPHAN

04-19-21

86 FR 20284

4/19/2021

II --> NC

2'-FLUORO ORTHO-FLUOROFENTANYL

04-27-21

86 FR 22113

4/27/2021

I

4'-METHYL ACETYL FENTANYL

04-27-21

86 FR 22113

4/27/2021

I

BETA-METHYL FENTANYL

04-27-21

86 FR 22113

4/27/2021

I

BETA'-PHENYL FENTANYL

04-27-21

86 FR 22113

4/27/2021

I

ORTHO-FLUOROBUTYRYL FENTANYL

04-27-21

86 FR 22113

4/27/2021

I

ORTHO-METHYL ACETYLFENTANYL

04-27-21

86 FR 22113

4/27/2021

I

ORTHO-METHYL METHOXYACETYL FENTANYL

04-27-21

86 FR 22113

4/27/2021

I

PARA-METHYLFENTANYL

04-27-21

86 FR 22113

4/27/2021

I

PHENYL FENTANYL

04-27-21

86 FR 22113

4/27/2021

I

THIOFURANYL FENTANYL

04-27-21

86 FR 22113

4/27/2021

I

FENTANYL CARBAMATE

05-04-21

86 FR 23602

5/4/2021

I

ORTHO-FLUOROACRYL FENTANYL

05-04-21

86 FR 23602

5/4/2021

I

ORTHO-FLUOROISOBUTYRYL FENTANYL

05-04-21

86 FR 23602

5/4/2021

I

PARA-FLUORO FURANYL FENTANYL

05-04-21

86 FR 23602

5/4/2021

I

SERDEXMETHYLPHENIDATE

05-07-21

86 FR 24487

5/7/2021

IV

Scheduling Actions - Chronological Order
29-Jul-24

Page 15 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

1-(4-CYANOBUTYL)-N-(2-PHENYLPROPAN-2-YL)-1HINDAZOLE-3-CARBOXAMIDE (4-CN-CUMYL-BUTINACA)

06-10-21

86 FR 30775

6/10/2021I

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1HPYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE (5F-CUMYLP7AICA)

06-10-21

86 FR 30775

6/10/2021

I

METHYL 2-(1-(CYCLOHEXYLMETHYL)-1H-INDOLE-3CARBOXAMIDO)-3-METHYLBUTANOATE (MMB-CHMICA,
AMB-CHMICA)

06-10-21

86 FR 30775

6/10/2021

I

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(5FLUOROPENTYL)-1H-INDAZOLE-3-CARBOXAMIDE (5F-ABPINACA)

06-10-21

86 FR 30775

6/10/2021

I

NAPHTHALEN-1-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXYLATE (NM2201; CBL2201)

06-10-21

86 FR 30775

6/10/2021I

1-(1,3-BENZODIOXOL-5-YL)-2-(ETHYLAMINO)-PENTAN-1ONE (N-ETHYLPENTYLONE, EPHYLONE)

06-14-21

86 FR 31427

6/14/2021

I

4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP)**

07-18-21

86 FR 37672

7/18/2021

I

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4CHLORO-A-PVP) **07-18-21

86 FR 37672

7/18/2021

I

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4MEAP) **07-18-21

86 FR 37672

7/18/2021

I

ALPHA-PYRROLIDINOHEPTAPHENONE (PV8) **07-18-21

86 FR 37672

7/18/2021

I

ALPHA-PYRROLIDINOHEXANOPHENONE (A-PHP) **07-18-21

86 FR 37672

7/18/2021

I

N-ETHYLHEXEDRONE **07-18-21

86 FR 37672

7/18/2021

I

PARA-METHOXYMETHAMPHETAMINE (PMMA), 1-(4METHOXYPHENYL)-N-METHYLPROPAN-2-AMINE

05-15-20

06-25-21

86 FR 33508

7/26/2021

I

4,4′-DIMETHYLAMINOREX (4,4′-DMAR; 4,5-DIHYDRO-4METHYL-5-(4-METHYLPHENYL)-2-OXAZOLAMINE)

04-07-20

08-12-21

86 FR 44270

9/13/2021

I

11-04-21

86 FR 60761

12/6/2021

I

ISOTONITAZENE (N,N-DIETHYL-2-(2-(4ISOPROPOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1YL)ETHAN-1-AMINE)
4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT)

01-14-22

01-14-22

87 FR 2376

I

5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT)

01-14-22

01-14-22

87 FR 2376

I

5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET)

01-14-22

01-14-22

87 FR 2376

I

5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO- 01-14-22
MiPT)

01-14-22

87 FR 2376

I

N,N-DIISOPROPYLTRYPTAMINE (DiPT)

01-14-22

87 FR 2376

I

(1-(4-FLUOROBENZYL)-1H-INDOL-3-YL)(2,2,3,3TETRAMETHYLCYCLOPROPYL)METHANONE (FUB-144)

04-07-22

87 FR 20318

4/7/2022I

1-(5-FLUOROPENTYL)-N-(2-PHENYLPROPAN-2-YL)-1HINDAZOLE-3-CARBOXAMIDE (5F-CUMYL-PINACA; SGT-25)

04-07-22

87 FR 20318

4/7/2022

I

DARIDOREXANT (QUVIVIQ)

04-07-22

87 FR 20313

4/7/2022

IV

ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDAZOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-EDMBPINACA)

04-07-22

87 FR 20318

4/7/2022

I

METHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE (5F-MDMBPICA)

04-07-22

87 FR 20318

4/7/2022I

01-14-22

Scheduling Actions - Chronological Order
29-Jul-24

Page 16 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEN-(ADAMANTAN-1-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE3-CARBOXAMIDE (FUB-AKB48; FUB-APINACA)

FEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE
04-07-22

87 FR 20318

4/7/2022I

2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC)

04-11-22

04-11-22

87 FR 21069

I

2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI)

04-11-22

04-11-22

87 FR 21069

I

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) *04-12-22

87 FR 21556

4/12/2022I

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,NDIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE) *04-12-22

87 FR 21556

4/12/2022I

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINOETONITAZENE) *04-12-22

87 FR 21556

4/12/2022

I

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1HBENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) *04-12-22

87 FR 21556

4/12/2022

I

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL1-YL)ETHAN-1-AMINE (METODESNITAZENE) *04-12-22

87 FR 21556

4/12/2022

I

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1HBENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE) *04-12-22

87 FR 21556

4/12/2022

I

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1HBENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE) *04-12-22

87 FR 21556

4/12/2022

I

3-ALPHA-HYDROXY-3-BETA-METHYL-5-ALPHA-PREGNAN20-ONE (GANAXOLONE)

06-01-22

87 FR 32991

6/1/2022V

4´-METHYL-ALPHA-PYRROLIDINOHEXIOPHENONE (MPHP)

06-01-22

87 FR 32996

6/1/2022

I

4'-CHLORO-ALPHA-PYRROLIDINOVALEROPHENONE (4CHLORO-A-PVP)

06-01-22

87 FR 32996

6/1/2022

I

4-METHYL-ALPHA-ETHYLAMINOPENTIOPHENONE (4MEAP)

06-01-22

87 FR 32996

6/1/2022

I

ALPHA-PYRROLIDINOHEPTAPHENONE (PV8)06-01-22

87 FR 32996

6/1/2022

I

ALPHA-PYRROLIDINOHEXANOPHENONE (A-PHP)

06-01-22

87 FR 32996

6/1/2022

I

N-ETHYLHEXEDRONE

06-01-22

87 FR 32996

6/1/2022I

7/6/2022

I

METHOXETAMINE

12-07-21

06-07-22

87 FR 34166

4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE (4-OH-DiPT)

01-14-22

07-27-22

87 FR 45076

I Withdrew
2022
proposedrule

5-METHOXY-ALPHA-METHYLTRYPTAMINE (5-MeO-AMT)

01-14-22

07-27-22

87 FR 45076

I Withdrew
2022
proposedrule

5-METHOXY-N,N-DIETHYLTRYPTAMINE (MeO-DET)

01-14-22

07-27-22

87 FR 45076

I Withdrew
2022
proposedrule

5-METHOXY-N-METHYL-N-ISOPROPYLTRYPTAMINE (5-MeO- 01-14-22
MiPT)

07-27-22

87 FR 45076

I Withdrew
2022
proposed
rule

Scheduling Actions - Chronological Order
29-Jul-24

Page 17 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

N,N-DIISOPROPYLTRYPTAMINE (DiPT)

01-14-22

07-27-22

87 FR 45076

I Withdrew
2022
proposedrule

2,5-DIMETHOXY-4-CHLOROAMPHETAMINE (DOC)

04-11-22

08-29-22

87 FR 52712

I Withdrew
2022
proposedrule

2,5-DIMETHOXY-4-IODOAMPHETAMINE (DOI)

04-11-22

08-29-22

87 FR 52712

I Withdrew
2022
proposed
rule

AMINEPTINE (7-[(10,11-DIHYDRO-5HDIBENZO[A,D]CYCLOHEPTEN-5-YL)AMINO]HEPTANOIC
ACID)

07-22-22

11-17-22

87 FR 68895

12/19/2022

I[18F]FP-CIT

11-04-21

11-21-22

87 FR 70715

12/21/2022

II --> NC

ZIPEPROL (1-METHOXY-3-[4-(2-METHOXY-2PHENYLETHYL)PIPERAZIN-1-YL]-1-PHENYLPROPAN-2-OL)

05-14-20

11-21-22

87 FR 70717

12/21/2022

I

MESOCARB (N-PHENYL-N'-(3-(1-PHENYLPROPAN-2-YL)1,2,3-OXADIAZOL-3-IUM-5-YL)CARBAMIMIDATE)

08-11-21

11-22-22

87 FR 71247

12/22/2022

I

FENFLURAMINE

07-19-22

12-23-22

87 FR 78857

12/23/2022

IV --> NC

METHIOPROPAMINE (N-METHYL-1-(THIOPHEN-2YL)PROPANE-2-AMINE

09-02-21

12-09-22

87 FR 75470

1/9/2023

I

1-(1-(1-(4-BROMOPHENYL)ETHYL)PIPERIDIN-4-YL)-1,3DIHYDRO-2H-BENZO[D]IMIDAZOL-2-ONE (BRORPHINE)

03-06-23

88 FR 13692

4/5/2023

I

EUTYLONE (1-(1,3-BENZODIOXOL-5-YL)-2(ETHYLAMINO)BUTAN-1-ONE)

04-10-23

88 FR 21101

4/10/2023

I

4-(2-CHLOROPHENYL)-2-ETHYL-9-METHYL-6H-THIENO[3,2F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE (ETIZOLAM) *07-26-23

88 FR 48112

7/26/2023I

6-(2-CHLOROPHENYL)-1-METHYL-8-NITRO-4HBENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE(CLONAZOLAM) *07-26-23

88 FR 48112

7/26/2023

I

7-CHLORO-5-(2-CHLOROPHENYL)-1-METHYL-1,3-DIHYDRO2H-BENZO[E][1,4]DIAZEPIN-2-ONE (DICLAZEPAM) *07-26-23

88 FR 48112

7/26/2023

I

8-BROMO-6-(2-FLUOROPHENYL)-1-METHYL-4HBENZO[F][1,2,4]TRAZOLO[4,3-A][1,4]DIAZEPINE(FLUBROMAZOLAM) *07-26-23

88 FR 48112

7/26/2023

I

8-CHLORO-6-(2-FLUOROPHENYL)-1-METHYL-4HBENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE(FLUALPRAZOLAM) *07-26-23

88 FR 48112

7/26/2023

I

ANABOLIC STEROIDS (amended regulations consistent withDASCA; updated and moved specific listing to 21 CFR
1308.13(f))

08-01-23

88 FR 50036

8/1/2023

III

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-5-NITRO-1HBENZIMIDAZOL-1-YL)ETHAN-1-AMINE (METONITAZENE)

08-18-23

88 FR 56466

9/18/2023

I

ZURANOLONE

10-31-23

88 FR 74347

10/31/2023

IV

2',5'-DIMETHOXYFENTANYL (N-(1-(2,5DIMETHOXYPHENETHYL)PIPERIDINE-4-YL)-NPHENYLPROPIONAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

3-FURANYL FENTANYL (N-(1-PHENTHYLPIPERIDIN-4-YL)-NPHENYLFURAN-3-CARBOXAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 18 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

ALPHA'-METHYL BUTYRYL FENTANYL (2-METHYL-N-(1PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

ISOVALERY FENTANYL (3-METHYL-N-(1PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

META-FLUOROFENTANYL (N-(3-FLUORPHENYL)-N-(1PHENETHYLPIPERIDIN-4-YL)ISOBUTYRAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

META-FLUOROISOBUTYRYL FENTANYL (N-(3FLUOROPHENYL)-N-(1-PHENYLPIPERIDIN-4YL)ISOBUTYRAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

ORTHO-FLUOROFURANYL FENTANYL (N-(2FLUOROPHENYL)-N-(1-PHENETHYLPIPERIDIN-4-YL)FURAN2-CARBOXAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

PARA-METHOXYFURANYL FENTANYL (N-(4METHOXYPHENYL)-N-(1-PHENETHYLPIPERIDIN-4YL)FURAN-2-CARBOXAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

PARA-METHYLCYCLOPROPYL FENTANYL (N-(4METHYLPHENYL)-N-(1-PHENYLPIPERIDIN-4YL)CYCLOPROPANECARBOXAMIDE)

12-07-23

88 FR 85104

12/7/2023

I

4F-MDMB-BUTICA (METHYL 2-[[1-(4-FLUOROBUTYL)INDOLE3-CARBONYL]AMINO]-3,3-DIMETHYL-BUTANOATE) *12-12-23

88 FR 86040

12/12/2023

I

5F-EDMB-PICA (ETHYL 2-[[1-5-FLUOROPENTYL)INDOLE-3CARBONYL]AMINO-3,3-DIMETHYL-BUTANOATE *12-12-23

88 FR 86040

12/12/2023

I

ADB-4EN-PINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN2-YL)-1-(PENT-4-EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE *12-12-23

88 FR 86040

12/12/2023

I

CUMYL-PEGACLONE (5-PENTYL-2-(2-PHENYLPROPAN-2YL)PYRIDO[4,3-B]INDOLE-1-ONE *12-12-23

88 FR 86040

12/12/2023

I

MDMB-4EN-PINACA (METHYL 3,3-DIMETHYL-2-(1-(PENT-4EN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDO)BUTANOATE) *12-12-23

88 FR 86040

12/12/2023

I

MMB-FUBICA (METHYL 2-(1-(4-FLUOROBENZYL)-1H-INDOLE3-CARBOXAMIDO)-3-METHYL BUTANOATE *12-12-23

88 FR 86040

12/12/2023

I

3-MMC (2-(METHYLAMINO)-1-(3-METHYLPHENYL)PROPAN-1ONE)

12-13-23

88 FR 86266

12/13/2023

I

ADB-BUTINACA (N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2YL)-1-BUTYL-1H-INDAZOLE-3-CARBOXAMIDE)

12-13-23

88 FR 86266

12/13/2023

I

ALPHA-PIHP (4-METHYL-1-PHENYL-2-(PYRROLIDIN-1YL)PENTAN-1-ONE)

12-13-23

88 FR 86266

12/13/2023

I

2-(2-(4-ETHOXYBENZYL)-1H-BENZIMIDAZOL-1-YL)-N,NDIETHYLETHAN-1-AMINE (ETODESNITAZENE; ETAZENE)

04-11-24

89 FR 25514

4/11/2024I

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PYRROLIDIN-1YL)ETHYL)-1H-BENZIMIDAZOLE (N-PYRROLIDINOETONITAZENE)

04-11-24

89 FR 25514

4/11/2024

I

N,N-DIETHYL-2-(5-NITRO-2-(4-PROPOXYBENZYL)-1HBENZIMIDAZOL-1-YL)ETHAN-1-AMINE (PROTONITAZENE)

04-11-24

89 FR 25514

4/11/2024I

2-(2-(4-BUTOXYBENZYL)-5-NITRO-1H-BENZIMIDAZOL-1-YL)N,N-DIETHYLETHAN-1-AMINE (BUTONITAZENE) **04-11-24

89 FR 25517

4/12/2024

I

N,N-DIETHYL-2-(2-(4-FLUOROBENZYL)-5-NITRO-1HBENZIMIDAZOL-1-YL)ETHAN-1-AMINE (FLUNITAZENE) **04-11-24

89 FR 25517

4/12/2024

I

N,N-DIETHYL-2-(2-(4-METHOXYBENZYL)-1H-BENZIMIDAZOL1-YL)ETHAN-1-AMINE (METODESNITAZENE) **04-11-24

89 FR 25517

4/12/2024

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 19 of 20

*Scheduled under 21 USC 811(h)**Extension of temporary control
NC = Not Controlled
SUBSTANCEFINAL ORDERPROPOSAL
PUBLICATIONDATEFEDERAL
PUBLICATION REGISTER EFFECTIVE
CSA
CITATIONDATEDATESCHEDULE

2-METHYL AP-237 (1-(2-METHYL-4-(3-PHENYLPROP-2-EN-1YL)PIPERAZIN-1-YL)BUTAN-1-ONE) *03-15-24

89 FR 18793

4/15/2024I

2-(4-ETHOXYBENZYL)-5-NITRO-1-(2-(PIPERIDIN-1YL)ETHYL)-1H-BENZIMIDAZOLE (N-PIPERIDINYLETONITAZENE; ETONITAZEPIPNE) *07-29-24

89 FR 60817

7/29/2024

I

N-ETHYL-2-(2-(4-ISOPROPOXYBENZYL)-5-NITRO-1HBENZIMIDAZOL-1-YL)ETHAN-1-AMINE (N-DESETHYL
ISOTONITAZENE) *07-29-24

89 FR 60817

7/29/2024

I

Scheduling Actions - Chronological Order
29-Jul-24

Page 20 of 20